Copaxone Teva must return non-MS Copaxone rights to Proneuron

The Supreme Court has upheld a ruling in the Tel Aviv District Court.

Tomer Hertz Is it worth getting vaccinated against flu?

Ben Gurion University researcher Dr. Tomer Hertz says flu jabs, like vaccinations against childhood diseases, are a social act that helps prevent infecting others.

Gal Salomon / Photo: Einat Levron , Globes AI healthcare analytics platform Clew raises $10m

The Israeli company's healthcare analytics platform delivers improved clinical and operational outcomes by predicting life-threatening complications.

David Baram and Shilo Ben-Zeev Gene editing co Emendo Biotherapeutics raises $61m

The company develops next-generation gene editing using synthetic biology to address untreatable diseases.

LifeBond's product Bard buys Israeli hernia mesh co LifeBond

The US medical device company will pay close to the $60 million that LifeBond has raised from investors.

Vincent Tchenguiz photo: Christopher Ratcliffe Israeli spacer balloon co BioProtect raises $13m

BioProtect's ProSpace balloon spacer protects prostate cancer patients undergoing radiation therapy.

drug development EU grants BiolineRX treatment orphan drug status

Last year, Motixafortide received Orphan Drug Designation for the treatment of Pancreatic Cancer from the US Food and Drug Administration (FDA).

Kare Schultz Photo: Shlomi Yosef Teva looks to China

At the JP Morgan Healthcare Conference, Teva CEO Kare Schultz said the company was on target with streamlining and debt reduction, and outlined its strategy for the Chinese market.

Dr. Daniel Drai  / Photo: PR Serojec develops drug to treat premature ejaculation

Dr. Daniel Drai's startup has patented a cocktail of drugs to prevent premature ejaculation. He says the market could be bigger than that of Viagra.

Teva Photo: Sivan Faraj Teva seeks blockbuster drug to succeed Copaxone

VP discovery David Wilson tells "Globes" that Teva is still an innovative company and has turned its attention back to Israel in the search for new drug candidates.

Copaxone Teva to pay $54m to settle Copaxone bribery case in US

Two former Teva sales representatives told how doctors were paid to prescribe branded drugs Copaxone and Azilect.

Insightec Charles Koch to invest $200-250m in Insightec

Koch Industries will become the controlling shareholder in the Israeli MRI guided ultrasound company.

Ron Hadassi  photo: Eyal Izhar Koch seen as the investor injecting $150m into Insightec

Koch Industries already owns 17% of the shares in Insightec.

Michelle Heymann and Diane Abensur / Photo: private photo Nanosynex aims to solve antibiotic resistance

The company has developed a way of precisely adapting antibiotics to infections.

Sheba ARC Innovation Center  / Photo: Cadya Levi Sheba Medical Center launches digital innovation center

The ARC center fosters local and international collaboration for digital healthcare projects, with on the spot input from doctors and nurses.

Twitter Facebook Linkedin RSS Newsletters גלובס Israel Business Conference 2018